Drug Pricing

Securing Affordable Treatments for All Americans

Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to rein in sky-high costs so that patients can afford the medications they need.

Facts & Figures

icon

ACHP plans partner with

Civica Rx

to address drug shortages and high prices.

image-card

FACT SHEET — Curbing High Drug Costs

Download
Resource Library Search

ACHP Statement on Drug Pricing

ACHP released a statement on drug pricing.

04/18/2025

Ending the Allure of Drug Advertising

ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad dominance. Patients should be able to access affordable, necessary medications, rather than being swayed by misleading marketing tactics.

ACHP Letter to Dr. Oz on Deregulation in Health Insurance

ACHP sent a letter to Dr. Mehmet Oz with commonsense reforms that cut unnecessary red tape and save precious health care dollars.

04/10/2025

ACHP Comments on CMS Marketplace Integrity & Affordability Proposed Rule

ACHP comments on the CMS Marketplace Integrity and Affordability Proposed Rule.

04/10/2025

ACHP Statement on CY2026 MA and Part D Rate Notice

ACHP commends the Trump Administration for finalizing policies in the 2026 MA and Part D Rate Notice that reflect higher care delivery costs and for taking another step toward reining …

04/07/2025

Loading…
icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow